尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Fahey Sandell Jacquelyn. Director active across 1 company, notably Voyager Therapeutics, Inc.. In total, 5 reports have been recorded. Split: 0 buy · 2 sells. Total volume traded: €50k. Activity tracked since 1 October 2023. The latest transaction was filed on 21 February 2025 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Fahey Sandell Jacquelyn is a declarant linked to Voyager Therapeutics, Inc., where the listed role is Chief Legal Officer. They have 5 filings in total, and across the 5 most recent filings held, sales total 50426 EUR with no buys, between 2023-10-02 and 2025-02-24.